Latest / Concord News Today | 2 Min News | The Daily News Now!
FDA Approves First Alzheimer’s Drug in Years | Concord News
FDA just approved Leqembi, the first drug in years to slow cognitive decline in early Alzheimer’s by targeting amyloid plaques — but with major caveats: serious side effects like brain swelling, costly treatment, and mandatory MRI monitoring. While it’s not a cure, it offers hope for preserving memory and independence in early-stage patients — and comes with the strongest warning label to reflect its risks. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.